Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Syros Pharmaceuticals
(NQ:
SYRS
)
2.510
UNCHANGED
Streaming Delayed Price
Updated: 11:30 AM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Syros Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
Next >
Syros Pharmaceuticals's Earnings Outlook
March 26, 2024
Via
Benzinga
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
March 25, 2024
From
Syros Pharmaceuticals
Via
Business Wire
Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
March 20, 2024
From
Syros Pharmaceuticals
Via
Business Wire
A Look Into Healthcare Sector Value Stocks
March 11, 2024
Via
Benzinga
Preview: Syros Pharmaceuticals's Earnings
November 13, 2023
Via
Benzinga
Earnings Outlook For Syros Pharmaceuticals
August 07, 2023
Via
Benzinga
Syros to Participate in TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
Syros Pharmaceuticals
Via
Business Wire
Overview Of Value Stocks In The Healthcare Sector
February 12, 2024
Via
Benzinga
3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential
January 31, 2024
Is your portfolio is in dire need of making new all-time highs? A new economic cycle is to send these penny stocks with potential up.
Via
InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
January 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 09, 2024
Via
Benzinga
Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene
January 08, 2024
From
Syros Pharmaceuticals
Via
Business Wire
5 Value Stocks To Watch In The Healthcare Sector
January 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 19, 2023
Via
Benzinga
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
December 19, 2023
From
Syros Pharmaceuticals
Via
Business Wire
Why Is Blood Cancer Focused Syros Pharmaceuticals Stock Soaring Today?
December 06, 2023
Syros Pharmaceuticals Inc (NASDAQ: SYRS) released initial data from its ongoing SELECT-AML-1 Phase 2 trial of tamibarotene in combination with venetoclax and azacitidine in newly diagnosed, unfit...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 06, 2023
Via
Benzinga
Syros Announces Encouraging Initial Data from Randomized SELECT-AML-1 Phase 2 Clinical Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine
December 06, 2023
From
Syros Pharmaceuticals
Via
Business Wire
Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential
December 03, 2023
Although even so-called penny stocks with potential carry dramatic risks, these four-baggers benefit from analyst backing.
Via
InvestorPlace
Syros to Participate in Upcoming Investor Conferences
November 21, 2023
From
Syros Pharmaceuticals
Via
Business Wire
Syros Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
November 14, 2023
From
Syros Pharmaceuticals
Via
Business Wire
Syros to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
November 07, 2023
From
Syros Pharmaceuticals
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
October 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 02, 2023
Via
Benzinga
Syros Announces Planned CEO Leadership Transition and Strategic Reorganization to Support Long-Term Business Growth and Maturation into a Commercial Biopharmaceutical Company
October 02, 2023
From
Syros Pharmaceuticals
Via
Business Wire
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 07, 2023
From
Syros Pharmaceuticals
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
August 11, 2023
Via
Benzinga
Syros Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
August 08, 2023
From
Syros Pharmaceuticals
Via
Business Wire
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023
From
Syros Pharmaceuticals
Via
Business Wire
Syros to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
August 01, 2023
From
Syros Pharmaceuticals
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.